Phase IIa dose-escalating trial investigating the tolerability and pharmacokinetics of AV 1142742 in patients receving concomitant methotrexate for severe rheumatoid arthritis
Phase of Trial: Phase II
Latest Information Update: 24 Jun 2008
At a glance
- Drugs AV 1142742 (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Biomarker; Pharmacokinetics
- 11 Nov 2007 The clinical part of this trial is expected to be completed in the first half of 2008.
- 25 Jan 2007 New trial record.